Effects of MaquiBright^® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial.

ABSTRACT: This study aims to investigate the effects of MaquiBright^®, also known as BrightSight^®, a standardized maqui berry extract, on improving eye dryness and fatigue in Japanese subjects (aged 30-60 years) experiencing eye dryness, eye fatigue, and ≥4 h of visual display terminal (VDT) work daily. Seventy-four participants were equally but randomly assigned to either a MaquiBright^® (MB) or a placebo (P) group, wherein each participant consumed one capsule daily for 4 weeks of the appropriate treatment (MaquiBright^® 60 or 0 mg). Eye dryness and fatigue were measured using the Schirmer's test, tear break-up time (BUT) test, pupillary response, and flicker test before intake and 4 weeks after intake. Furthermore, subjective symptoms were assessed using t

SUBMITTER: Yamashita SI 

PROVIDER: S-EPMC6544612 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature